Azitra, Inc. (NYSEAMERICAN:AZTR – Free Report) shares are set to reverse split on Monday, July 1st. The 1-30 reverse split was announced on Monday, July 1st. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, July 1st.
Azitra Price Performance
Shares of AZTR stock opened at $0.09 on Friday. Azitra has a 12-month low of $0.09 and a 12-month high of $4.33. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.80 and a quick ratio of 2.80.
Azitra (NYSEAMERICAN:AZTR – Get Free Report) last released its quarterly earnings results on Thursday, May 9th. The company reported ($0.15) EPS for the quarter. Azitra had a negative net margin of 1,644.90% and a negative return on equity of 237.52%.
About Azitra
Azitra, Inc, an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease.
Recommended Stories
- Five stocks we like better than Azitra
- What is MarketRank™? How to Use it
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- What Does a Stock Split Mean?
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for Azitra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azitra and related companies with MarketBeat.com's FREE daily email newsletter.
